BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horwath-Winter, J
Right arrow Articles by Rieger, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horwath-Winter, J
Right arrow Articles by Rieger, G
Topic Collections
Right arrowRelevant Article
British Journal of Ophthalmology 2005;89:40-44
© 2005 BMJ Publishing Group Ltd


EXTENDED REPORT

Iodide iontophoresis as a treatment for dry eye syndrome

J Horwath-Winter1, O Schmut1, E-M Haller-Schober1, A Gruber1, G Rieger2

1 Department of Ophthalmology, Medical University, Graz, Austria
2 Paracelsus Society for Balneology and Iodine Research, Bad Hall, Austria

Correspondence to:
Correspondence to:
Jutta Horwath-Winter
Department of Ophthalmology, Auenbruggerplatz 4, A-8036 Graz, Austria; jutta.horwath{at}meduni-graz.at

Background/aims: Among the causes related to the development or perpetuation and aggravation of dry eye disease, oxidative reactions may have a role in the pathogenesis of this disorder. Antioxidants, such as iodide, have shown a strong effect in preventing the oxidative damage to constituents of the anterior part of the eye. In this clinical trial the effectiveness of iodide iontophoresis and iodide application without current in moderate to severe dry eye patients was compared.

Methods: 16 patients were treated with iodide iontophoresis and 12 patients with iodide application without current for 10 days. Subjective improvement, frequency of artificial tear application, tear function parameters (break up time, Schirmer test without local anaesthesia), vital staining (fluorescein and rose bengal staining) as well as impression cytology of the bulbar conjunctiva were evaluated before treatment, 1 week, 1 month, and 3 months after treatment.

Results: A reduction in subjective symptoms, frequency of artificial tear substitute application, and an improvement in certain tear film and ocular surface factors could be observed in both groups. A stronger positive influence was seen after application of iodide with current (iontophoresis), as observed in a distinct improvement in break up time, fluorescein and rose bengal staining, and in a longer duration of this effect compared with the non-current group. No significant change in Schirmer test results and impression cytology were observed in both groups.

Conclusions: Iodide iontophoresis has been demonstrated to be a safe and well tolerated method of improving subjective and objective dry eye factors in patients with ocular surface disease.


Abbreviations: BUT, break up time; ROS, reactive oxygen species

Keywords: dry eye; keratoconjunctivitis sicca; iodide; iontophoresis


Relevant Article

BJO at a glance
Creig Hoyt
Br. J. Ophthalmol. 2005 89: 1a. [Extract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.